Concepedia

Chris Twitty

CT

17

Publications

1.9K

Citations

15

H-Index

2004

Active since

Affiliations

Providence Portland Medical Center(Current)

Cancer Research Center

University of California, San Francisco

Oregon Health & Science University

Fred Hutch Cancer Center

Chris Twitty is an author at Providence Portland Medical Center specializing in immunology, medicine, and immunotherapy.

ORCID

Top concepts

Publications per year

2004–2022

17

Publications

17

Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

Christopher Garris, Sean P. Arlauckas, Rainer H. Köhler et al. · Immunity · 2018 · 899 citations · Full text

, , +12

Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma

Alain P. Algazi, Chris Twitty, Katy K. Tsai et al. · Clinical Cancer Research · 2020 · 139 citations · Full text

Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients

Alain P. Algazi, Shailender Bhatia, Sanjiv S. Agarwala et al. · Annals of Oncology · 2020 · 125 citations · Full text

Tumor-Derived Autophagosome Vaccine: Induction of Cross-Protective Immune Responses against Short-lived Proteins through a p62-Dependent Mechanism

Chris Twitty, Shawn M. Jensen, Hong‐Ming Hu et al. · Clinical Cancer Research · 2011 · 91 citations · Full text

Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses

Samantha K. Greaney, Alain P. Algazi, Katy K. Tsai et al. · Cancer Immunology Research · 2019 · 91 citations · Full text

Rows per page

1–5 of 17